XML 145 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Estimate the Fair Value of Stock Options Granted The assumptions used to estimate the fair value of stock options granted during the year ended December 31, 2024 are as follows:
Year ended December 31,
2024
Expected dividend yield
Expected volatility
103.0% - 107.0%
Expected term (years)
5.0 - 6.1
Risk free interest
4.0% - 4.2%
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):
Number of optionsWeighted  average  exercise  price  ($)Weighted average remaining contractual term (years)Aggregate intrinsic value ($)
Outstanding as of December 31, 2023*
10,300,5671.73 6.81— 
Granted2,921,0821.30 
Exercised(1,911,119)0.90 
Forfeited and expired(325,792)4.76 
Outstanding as of December 31, 202410,984,7381.67 6.6475,270 
Options exercisable as of December 31, 20249,145,6521.46 6.2564,379 
Options unvested as of December 31, 20241,839,0862.68 8.5910,891 
*As of December 31, 2023, a total of 10,547,844 options had been issued and remained outstanding under the 2020 Plan. The number of options, along with the weighted average exercise price and weighted average remaining contractual term shown in the table above, have been adjusted to the as-converted number of Commons Shares using the Conversion Ratio applied to these 10,547,844 options.
Schedule of RSU Activity and Related Information
The following table summarizes the RSU activity and related information under the 2022 Plan (in thousands except share and per share data):
Number of RSUsWeighted average Grant Date Fair Value ($)
Unvested as of December 31, 20237,045,813 3.13 
Granted7,058,265 1.66 
Forfeited and expired(553,478)2.14 
Vested(4,763,578)2.69 
Unvested as of December 31, 20248,787,022 2.25 
Schedule of Stock-Based Compensation Expense
The following table summarizes the stock-based compensation expense classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
Year Ended December 31,
20242023
Cost of revenue$647 $1,272 
Research and development5,0898,286
General and administrative8,166 11,356 
Sales and marketing1,759 1,005 
Total stock-based compensation$15,661 $21,919